INBS - Intelligent Bio Solutions Inc. Stock Price and Quote

INBS [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-6.67	Insider Own	1.90%	Shs Outstand	0.91M	Perf Week	-9.84%
Market Cap	4.37M	Forward P/E	-	EPS next Y	-4.51	Insider Trans	0.00%	Shs Float	0.74M	Perf Month	-54.70%
Income	-5.00M	PEG	-	EPS next Q	-2.07	Inst Own	1.90%	Short Float / Ratio	2.58% / 0.10	Perf Quarter	-26.42%
Sales	0.90M	P/S	4.86	EPS this Y	16.20%	Inst Trans	-72.20%	Short Interest	0.02M	Perf Half Y	-65.80%
Book/sh	11.37	P/B	0.25	EPS next Y	53.10%	ROA	-36.70%	Target Price	23.50	Perf Year	-81.61%
Cash/sh	1.88	P/C	1.51	EPS next 5Y	-	ROE	-65.00%	52W Range	2.63 - 32.00	Perf YTD	-28.96%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-126.30%	52W High	-91.13%	Beta	-
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	467.90%	Gross Margin	87.90%	52W Low	8.14%	ATR	0.62
Employees	12	Current Ratio	1.30	Sales Q/Q	100.00%	Oper. Margin	-	RSI (14)	30.79	Volatility	8.15% 9.11%
Optionable	No	Debt/Eq	0.18	EPS Q/Q	90.00%	Profit Margin	-	Rel Volume	0.02	Prev Close	2.86
Shortable	Yes	LT Debt/Eq	0.14	Earnings	Feb 14 BMO	Payout	-	Avg Volume	191.29K	Price	2.84
Recom	1.00	SMA20	-20.40%	SMA50	-66.05%	SMA200	-70.96%	Volume	4,265	Change	-0.70%

Mar-27-23 07:30AM	A & F Sprinklers Selects Intelligent Bio Solutions Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program GlobeNewswire
Mar-13-23 08:30AM	Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia GlobeNewswire -5.03%
Mar-10-23 04:01PM	Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares and Warrants GlobeNewswire
Mar-09-23 04:39AM	INBS: Valuation Update on 2Q:23 Results Zacks Small Cap Research -9.41%
Mar-08-23 08:30AM	Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering GlobeNewswire -42.66%
04:07PM	Loading…
Mar-07-23 04:07PM	Intelligent Bio Solutions Inc. Announces Proposed Public Offering GlobeNewswire
Mar-01-23 08:30AM	Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement GlobeNewswire
Feb-16-23 08:30AM	Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge GlobeNewswire +5.31%
Feb-14-23 08:14AM	Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights GlobeNewswire
Feb-09-23 12:15PM	Intelligent Bio Solutions Inc. Announces Reverse Stock Split GlobeNewswire -16.63%
Feb-07-23 07:30AM	Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing GlobeNewswire +8.56%
Jan-31-23 08:31AM	Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests GlobeNewswire -5.65%
Jan-23-23 10:28AM	Why Intelligent Bio Solutions Shares Skyrocketing Over 400% Today? Benzinga +293.13%
07:30AM	Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development GlobeNewswire
Dec-22-22 05:02PM	Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering GlobeNewswire
04:30PM	Loading…
Dec-21-22 04:30PM	Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders GlobeNewswire
Nov-09-22 04:05PM	Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights GlobeNewswire
Nov-08-22 06:17AM	INBS: Its Touch and Go From Here Zacks Small Cap Research -6.65%
Nov-07-22 08:30AM	Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations GlobeNewswire -5.10%
Nov-03-22 08:30AM	Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing GlobeNewswire
Nov-02-22 04:05PM	Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9 GlobeNewswire
Oct-31-22 09:05AM	Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing GlobeNewswire -6.48%

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience